These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 7800904)

  • 1. [A change in the prescription of thrombolytic treatment in elderly patients. The experience of the Hospital de León].
    Alonso-Orcajo N; Franco Aranda C; García Calabozo R; Fidalgo Andrés ML; Rodríguez García MA; Bayón Fernández J; García Porrero E; Martínez-Sande JL; Simarro E
    Rev Esp Cardiol; 1994 Nov; 47(11):741-6. PubMed ID: 7800904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thrombolytic therapy in acute myocardial infarct--is it being used to the fullest?].
    Carôla B; Calçada-Correia L; Pedro PG; Conduto R; Dionísio I; Fiuza M; Dias E; Vaz Carneiro A; Amador MG; de Pádua F; Lopes MG
    Rev Port Cardiol; 1996 Dec; 15(12):867-76, 863. PubMed ID: 9052962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The safety and efficacy of systemic salvage thrombolysis in acute myocardial infarct].
    Sarullo FM; Schicchi R; Schirò M; Americo L; Bonnì G; Faraone N; Di Pasquale P; Castello A; Mauri F
    Ital Heart J Suppl; 2000 Jan; 1(1):81-7. PubMed ID: 10832123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Endovenous thrombolysis in acute myocardial infarct. The experience in a community hospital. An analysis of 120 patients].
    Jorge Sdo C
    Arq Bras Cardiol; 1992 Jul; 59(1):23-30. PubMed ID: 1341143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of thrombolysis with alteplase (50 mg) plus tirofiban versus alteplase (100 mg) alone in acute myocardial infarction: preliminary findings.
    Sarullo FM; Pasquale PD; D'Alfonso G; Amerigo L; Cannizzaro S; Castello A
    Ital Heart J; 2001 Aug; 2(8):605-11. PubMed ID: 11577835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The safety of the treatment of an acute myocardial infarct by immediate intravenous fibrinolysis in the regional hospital environment].
    Bermejo García J; Casero Lambás A; Durán Hernández JM; Alonso Martín J; Ramos López B; Muñoz San José JC; Guillem Ares E; Bartolomé Aragón A; Gamazo Chillón F; San José Díez J
    Rev Esp Cardiol; 1994 Oct; 47(10):666-71. PubMed ID: 7991919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thrombolytic therapy in acute myocardial infarct. New performance protocols. Their influence on mortality and the incidence of complications].
    Torres Martínez G; Rodríguez García P; Galcerá Tomás J; Castillo Soria F; Cantón Martínez A; Palazón Sánchez C; Seller Pérez G
    Rev Esp Cardiol; 1993 Apr; 46(4):235-41. PubMed ID: 8469808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intracranial hemorrhage following thrombolytic therapy in acute myocardial infarct].
    Torres Martínez G; Rodríguez García P; Cantón Martínez A; Castillo Soria F; Galcerá Tomás J; García Paredes T; Bru Cartagena M; Jara Pérez P
    Rev Esp Cardiol; 1994 Feb; 47(2):73-80. PubMed ID: 8165351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-related trends (1986-1993) in the use of thrombolytic agents in patients with acute myocardial infarction. The Worcester Heart Attack Study.
    Chandra H; Yarzebski J; Goldberg RJ; Savageau J; Singleton C; Gurwitz JH; Gore JM
    Arch Intern Med; 1997 Apr; 157(7):741-6. PubMed ID: 9125005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical characteristics and hospital mortality of acute myocardial infarction in elderly patients treated with thrombolytic agents].
    Pabón Osuna P; Bermeio García J; Arribas Jiménez A; Nieto Ballesteros F; Sáez Jiménez A; Martin Luengo C; Fernández Avilés F; de la Torre Carpete M; Garcimartín Cerrón I
    Rev Esp Cardiol; 1996 Jul; 49(7):501-8. PubMed ID: 8754444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with delay in reperfusion therapy in elderly patients with acute myocardial infarction: analysis of the cooperative cardiovascular project.
    Berger AK; Radford MJ; Krumholz HM
    Am Heart J; 2000 Jun; 139(6):985-92. PubMed ID: 10827378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Usefulness and safety of intravenous thrombolytic therapy for elderly patients with acute myocardial infarction: relationship with cardiac rupture].
    Sakai M; Imai T; Kuboki K; Maeda S; Ueda S; Kuwajima I; Ohkawa S; Matsushita S
    J Cardiol; 1999 Mar; 33(3):153-61. PubMed ID: 10225195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of thrombolytic therapy in relation to hospital size and invasive cardiac services. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.
    Barbash GI; White HD; Modan M; Diaz R; Hampton JR; Heikkila J; Kristinsson A; Moulopoulos S; Paolasso EA; Van der Werf T
    Arch Intern Med; 1994 Oct; 154(19):2237-42. PubMed ID: 7944845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Successive ischemic events to a first acute myocardial infarct treated with fibrinolysis. An analysis of GISSI-2 patients considered reperfused by a clinical criterion. Participants in the GISSI-2 study. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico].
    Bardelli G; Maggi G; Maggi A; Barlera S
    G Ital Cardiol; 1995 Apr; 25(4):463-72. PubMed ID: 7642053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombolytic therapy impact on prognosis after twelve months of first acute myocardial infarction.
    Caires G; Pereira D; Freitas AD; Teixeira F; Leite R; Araújo JJ; Cardoso A; Pereira AC; Macedo ME; Diniz M
    Rev Port Cardiol; 2000 Nov; 19(11):1103-19. PubMed ID: 11201627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TERIMA-2: national extension of thrombolytic treatment with recombinant streptokinase in acute myocardial infarct in Cuba.
    TERIMA Group of Investigators
    Thromb Haemost; 2000 Dec; 84(6):949-54. PubMed ID: 11330244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Management of acute myocardial infarction in the experience of a community hospital. A prospective study].
    Tincani E; Mazzoli V; Bondi M
    Minerva Cardioangiol; 1997; 45(7-8):335-47. PubMed ID: 9463169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A randomized study of streptokinase and recombinant tissue plasminogen activator, with and without heparin, in patients with acute myocardial infarction. The results of GISSI-2/International tPA/SK Mortality Trial].
    Steffensen R; Sandøe E
    Ugeskr Laeger; 1991 Oct; 153(41):2880-3. PubMed ID: 1949301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Varying thrombolytic administration rates in elderly patients with acute myocardial infarction.
    Farnsworth TA
    Br J Clin Pract; 1993; 47(6):305-7. PubMed ID: 8117551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of different reperfusion strategies in patients with former contraindications to thrombolytic therapy: a comparison of primary angioplasty and tissue plasminogen activator. Primary Angioplasty in Myocardial Infarction (PAMI) Investigators.
    Stone GW; Grines CL; Browne KF; Marco J; Rothbaum D; O'Keefe JH; Hartzler GO; Overlie P; Donohue B; Chelliah N; Vlietstra R; Puchrowicz-Ochocki S; O'Neill WW
    Cathet Cardiovasc Diagn; 1996 Dec; 39(4):333-9. PubMed ID: 8958418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.